

Kira Pharmaceuticals, a developer of therapies to treat immune-mediated diseases, has secured $46 million in funding. The backers included Quan Capital, 6 Dimensions Capital, Qiming Venture Partners and Sinopharm Capital.
Source: Press Release
Kira Pharmaceuticals, a developer of therapies to treat immune-mediated diseases, has secured $46 million in funding.
Kira Pharmaceuticals, a developer of therapies to treat immune-mediated diseases, has secured $46 million in funding. The backers included Quan Capital, 6 Dimensions Capital, Qiming Venture Partners and Sinopharm Capital.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination